HCA Healthcare may be 35% undervalued according to a widely followed narrative, which sets a fair value of $629.14 against a last close of $410.61. The stock has fallen 19.04% over the past 90 days and 12.71% year to date, underperforming the S&P 500, amid a Barclays downgrade and index removals. The narrative assumes steady revenue expansion, resilient margins, and disciplined future earnings, though risks include elevated labor costs and tighter reimbursement terms. Long-term holders have still seen a 95.75% total return over five years.
HCA Healthcare, Inc.Article claims HCA is 35% undervalued with a fair value of $629.14, implying upside despite recent downgrades and index exits.